DocDollars

Covidien LP

MN · United States · Reporting entity ID 100000000083

Total reported 2019–2025
$19.4M
#326 of 2,960 reporting companies — 0% of all reported industry payments
$13.8M in general payments across 28,195 records, plus $5.60M in research funding across 845 records.

How it breaks down

General payments $13,828,371
Research funding $5,601,500

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Covidien LP reported $19.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #326 of 2,960 reporting companies. 29% of that was research funding and 71% general payments such as consulting, speaking, food and travel. 28,195 general payment records and 845 research records were filed.

Common questions about Covidien LP

How much has Covidien LP paid US doctors?

Covidien LP reported $19,429,871 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,828,371 in general payments, $5,601,500 in research funding.

How does Covidien LP rank among drug and device companies?

It ranks #326 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Covidien LP mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.